Request Deal Involvement
Keensight Capital completed the acquisition of Inke from Neuraxpharm for $263m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Clifford Chance
financial advisors
Jefferies & Company
financial advisors
Bain & Co
legal advisors
Garrigues
financial advisors
Rothschild & Co
legal advisors
Paul Hastings
financial advisors
Alvarez & Marsal
or
Principals
vendor
NEURAXPHARM
bidder
KEENSIGHT CAPITAL
target
INKE
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite